These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8250970)

  • 21. Coupling of mitosis to the completion of S phase in Xenopus occurs via modulation of the tyrosine kinase that phosphorylates p34cdc2.
    Smythe C; Newport JW
    Cell; 1992 Feb; 68(4):787-97. PubMed ID: 1531451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
    Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From ovocyte to biochemistry of the cell cycle].
    Ozon R
    Verh K Acad Geneeskd Belg; 1991; 53(4):365-85. PubMed ID: 1659057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex.
    Faaland CA; Adhikarakunnathu S; Thomas T; Thomas TJ
    Breast Cancer Res Treat; 1997 May; 44(1):47-56. PubMed ID: 9164677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint.
    Tuel-Ahlgren L; Jun X; Waddick KG; Jin J; Bolen J; Uckun FM
    Leuk Lymphoma; 1996 Feb; 20(5-6):417-26. PubMed ID: 8833397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.
    Krek W; Nigg EA
    EMBO J; 1991 Feb; 10(2):305-16. PubMed ID: 1846803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-beta-D-arabinofuranosylcytosine activates tyrosine phosphorylation of p34cdc2 and its association with the Src-like p56/p53lyn kinase in human myeloid leukemia cells.
    Yuan ZM; Kharbanda S; Kufe D
    Biochemistry; 1995 Jan; 34(3):1058-63. PubMed ID: 7530044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates.
    Norbury C; Blow J; Nurse P
    EMBO J; 1991 Nov; 10(11):3321-9. PubMed ID: 1655417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of cisplatin on cell cycle regulators].
    Nishio K; Saijo N
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):289-94. PubMed ID: 8109984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
    Lock RB
    Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokinin controls the cell cycle at mitosis by stimulating the tyrosine dephosphorylation and activation of p34cdc2-like H1 histone kinase.
    Zhang K; Letham DS; John PC
    Planta; 1996; 200(1):2-12. PubMed ID: 8987615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.
    Shen SC; Huang TS; Jee SH; Kuo ML
    Cell Growth Differ; 1998 Jan; 9(1):23-9. PubMed ID: 9438385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates.
    Krek W; Nigg EA
    EMBO J; 1991 Nov; 10(11):3331-41. PubMed ID: 1655418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori inhibits activity of cdc2 kinase and delays G2/M to G1 progression in gastric adenocarcinoma cell line.
    Chiou CC; Chan CC; Kuo YP; Chan EC
    Scand J Gastroenterol; 2003 Feb; 38(2):147-52. PubMed ID: 12678330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian virus 40 prevents activation of M-phase-promoting factor during lytic infection.
    Scarano FJ; Laffin JA; Lehman JM; Friedrich TD
    J Virol; 1994 Apr; 68(4):2355-61. PubMed ID: 8139021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the cytoplasmic proline-directed protein kinase in proliferative cells and tissues as a heterodimer comprised of p34cdc2 and p58cyclin A.
    Hall FL; Braun RK; Mihara K; Fung YK; Berndt N; Carbonaro-Hall DA; Vulliet PR
    J Biol Chem; 1991 Sep; 266(26):17430-40. PubMed ID: 1832672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase.
    Solomon MJ; Lee T; Kirschner MW
    Mol Biol Cell; 1992 Jan; 3(1):13-27. PubMed ID: 1532335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthesis of p58cyclin A and the phosphorylation of p34cdc2 are inhibited in human lymphoid cells arrested in G1 by alpha-interferon.
    Bybee A; Thomas NS
    Biochim Biophys Acta; 1992 Oct; 1137(1):73-6. PubMed ID: 1390903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.